Skip to content

Emergency Pancreaticoduodenectomy: a Non-trauma Center Case Series

Emergency Pancreaticoduodenectomy: a Non-trauma Center Case Series

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05139394
Enrollment
4
Registered
2021-12-01
Start date
2014-01-31
Completion date
2021-09-30
Last updated
2021-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergencies, Pancreas Disease

Brief summary

Pancreaticoduodenectomy is a challenging procedure itself, being even more complex and demanding in emergency settings. Only a few cases of emergency pancreaticoduodenectomy (EPD) are reported in medical literature, usually performed for complex pancreaticoduodenal lesions. EPD has first been mentioned in trauma settings, even fewer cases being reported for non-traumatic indications. The investigators intend to present our experience with this intervention, in a non-trauma surgical centre. Our study is a prospective consecutive case series, that included patients that underwent emergency pancreaticoduodenectomy from January 2014 to May 2021. Data was collected from the electronic system database. The investigators collected data regarding the demographic characteristics of the patients, their medical history, preoperative and postoperative investigations (including blood work and imagistic investigations), surgery related information and postoperative evolution.

Interventions

PROCEDUREemergency pancreaticoduodenectomy

Emergency pancreaticoduodenectomy (EPD) is a complex surgical procedure, that can be performed for complex pancreaticoduodenal injuries, that cannot be controlled through less invasive procedures. EPD can be performed either as a classical Whipple procedure, or as a pylorus-preserving procedure. A one stage procedure implies the reconstruction step being done in the same surgical intervention, while a two step procedure implies the reconstruction being done in a later stage, through a second surgical intervention.

Sponsors

Iuliu Hatieganu University of Medicine and Pharmacy
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Emergency pancreaticoduodenectomy performed

Exclusion criteria

* Elective surgery * Insufficient data

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative blood lossThe length of the surgical intervention (an average of 3 hours)ml of blood
Operative timeThe length of the surgical intervention (an average of 3 hours)minutes of operating time
In-hospital MorbidityUp to 90 days. Through study completion, during the hospital admission period
In-hospital MortalityUp to 90 days. Through study completion, during the hospital admission period
Long-term evolutionThe date of the last follow-up information was August 2021It will be measured the overall survival time, number of readmissions and number of reinterventions

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026